{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:18:26Z","timestamp":1778591906453,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T00:00:00Z","timestamp":1465171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T00:00:00Z","timestamp":1465171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1038\/bmt.2016.150","type":"journal-article","created":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T13:47:08Z","timestamp":1465220828000},"page":"1369-1375","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ovarian function after hematopoietic cell transplantation: a descriptive study following the use of GnRH agonists for myeloablative conditioning and observation only for reduced-intensity conditioning"],"prefix":"10.1038","volume":"51","author":[{"given":"R","family":"Phelan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Napurski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T E","family":"DeFor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Petryk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W P","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M R","family":"Verneris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A R","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,6,6]]},"reference":[{"key":"BFbmt2016150_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3109\/09513590009167696","volume":"14","author":"T Laml","year":"2000","unstructured":"Laml T, Schulz-Lobmeyr I, Obruca A, Huber JC, Hartmann BW . Premature ovarian failure: etiology and prospects. Gynecol Endocrinol 2000; 14: 292\u2013302.","journal-title":"Gynecol Endocrinol"},{"key":"BFbmt2016150_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/09513590500099255","volume":"21","author":"M Somali","year":"2005","unstructured":"Somali M, Mpatakoias V, Avramides A, Sakellari I, Kaloyannidis P, Smias C et al. Function of the hypothalamic-pituitary gonadal axis in long-term survivors of hematopoietic stem cell transplantation for hematological diseases. Gynecol Endocrinol 2005; 21: 18\u201326.","journal-title":"Gynecol Endocrinol"},{"key":"BFbmt2016150_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/sj.bmt.1701342","volume":"22","author":"AC Mertens","year":"1998","unstructured":"Mertens AC, Ramsay NK, Kouris S, Neglia JP . Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant 1998; 22: 345\u2013350.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016150_CR4","first-page":"1725","volume":"90","author":"YC Cheng","year":"2005","unstructured":"Cheng YC, Saliba RM, Rond\u00f3n G, Giralt SA, Lu KH, Bodurka DC et al. Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation. Haematologica 2005; 90: 1725\u20131726.","journal-title":"Haematologica"},{"key":"BFbmt2016150_CR5","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/bmt.2011.14","volume":"47","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Sawada A, Yamada K, Kondo W, Koyama-Sato M, Shimizu S et al. Encouraging results of preserving ovarian function after allo-HSCT with RIC. Bone Marrow Transplant 2012; 47: 141\u2013142.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016150_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ajh.2830420404","volume":"42","author":"R Ghalie","year":"1993","unstructured":"Ghalie R, Porter C, Radwanska E, Fitzsimmons W, Richman C, Kaizer H . Prevention of hypermenorrhea with leuprolide in premenopausal women undergoing bone marrow transplantation. Am J Hematol 1993; 42: 350\u2013353.","journal-title":"Am J Hematol"},{"key":"BFbmt2016150_CR7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/sj.bmt.1701187","volume":"21","author":"P Chiusolo","year":"1998","unstructured":"Chiusolo P, Salutari P, Sica S, Scirpa P, Laurenti L, Piccirillo N et al. Luteinizing hormone-releasing hormone analogue: leuprorelin acetate for the prevention of menstrual bleeding in premenopausal women undergoing stem cell transplantation. Bone Marrow Transplant 1998; 21: 821\u2013823.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016150_CR8","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1634\/theoncologist.12-9-1044","volume":"12","author":"Z Blumenfeld","year":"2007","unstructured":"Blumenfeld Z . How to preserve fertility in young women exposed to chemotherapy? The role of GnRH agonist cotreatment in addition to cryopreservation of embrya, oocytes, or ovaries. Oncologist 2007; 12: 1044\u20131054.","journal-title":"Oncologist"},{"key":"BFbmt2016150_CR9","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.fertnstert.2007.12.044","volume":"91","author":"A Badawy","year":"2009","unstructured":"Badawy A, Elnashar A, El-Ashry M, Shahat M . Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study. Fertil Steril 2009; 91: 694\u2013697.","journal-title":"Fertil Steril"},{"key":"BFbmt2016150_CR10","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1093\/oxfordjournals.humrep.a019457","volume":"11","author":"Z Blumenfeld","year":"1996","unstructured":"Blumenfeld Z, Avivi I, Linn S, Epelbaum R, Ben-Shahar M, Haim N . Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod 1996; 11: 1620\u20131626.","journal-title":"Hum Reprod"},{"key":"BFbmt2016150_CR11","first-page":"269","volume":"306","author":"L Del Mastro","year":"2011","unstructured":"Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 2011; 306: 269\u2013276.","journal-title":"JAMA"},{"key":"BFbmt2016150_CR12","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1006\/gyno.2001.6181","volume":"81","author":"B Pereyra Pacheco","year":"2001","unstructured":"Pereyra Pacheco B, M\u00e9ndez Ribas JM, Milone G, Fernandez I, Kvicala R, Mila T et al. Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report. Gynecol Oncol 2001; 81: 391\u2013397.","journal-title":"Gynecol Oncol"},{"key":"BFbmt2016150_CR13","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/bmt.2011.78","volume":"47","author":"A Borgmann-Staudt","year":"2012","unstructured":"Borgmann-Staudt A, Rendtorff R, Reinmuth S, Hohmann C, Keil T, Schuster FR et al. Fertility after allogeneic haematopoietic stem cell transplantation in childhood and adolescence. Bone Marrow Transplant 2012; 47: 271\u2013276.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016150_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbmt.2010.07.009","volume":"17","author":"AW Loren","year":"2011","unstructured":"Loren AW, Chow E, Jacobsohn DA, Gileece M, Halter J, Joshi S et al. Pregnancy after hematopoietic cell transplantation: a report from the late effects working committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). Biol Blood Marrow Transplant 2011; 17: 157\u2013166.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016150_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/EJE-13-0694","volume":"170","author":"A Vatanen","year":"2014","unstructured":"Vatanen A, Wilhelmsson M, Borgstr\u00f6m B, Gustafsson B, Taskinen M, Saarinen-Pihkala UM et al. Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence. Eur J Endocrinol 2014; 170: 211\u2013218.","journal-title":"Eur J Endocrinol"},{"key":"BFbmt2016150_CR16","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/cncr.10773","volume":"95","author":"L Tauchmanov\u00e0","year":"2002","unstructured":"Tauchmanov\u00e0 L, Selleri C, Rosa GD, Pagano L, Orio F, Lombardi G et al. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases. Cancer 2002; 95: 1076\u20131084.","journal-title":"Cancer"},{"key":"BFbmt2016150_CR17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1089\/jwh.2008.0857","volume":"18","author":"ME Clowse","year":"2009","unstructured":"Clowse ME, Behera MA, Anders CK, Copland S, Coffman CJ, Leppert PC et al. Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis. J Womens Health (Larchmt) 2009; 18: 311\u2013319.","journal-title":"J Womens Health (Larchmt)"},{"key":"BFbmt2016150_CR18","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1517\/14656566.2015.1031654","volume":"16","author":"Z Blumenfeld","year":"2015","unstructured":"Blumenfeld Z, Evron A . Preserving fertility when choosing chemotherapy regimens\u2014the role of gonadotropin-releasing hormone agonists. Expert Opin Pharmacother 2015; 16: 1009\u20131020.","journal-title":"Expert Opin Pharmacother"},{"key":"BFbmt2016150_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1634\/theoncologist.2011-0205","volume":"17","author":"YC Cheng","year":"2012","unstructured":"Cheng YC, Takagi M, Milbourne A, Champlin RE, Ueno NT . Phase II study of gonadotropin-releasing hormone analog for ovarian function preservation in hematopoietic stem cell transplantation patients. Oncologist 2012; 17: 233\u2013238.","journal-title":"Oncologist"},{"key":"BFbmt2016150_CR20","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.fertnstert.2012.07.1144","volume":"98","author":"Z Blumenfeld","year":"2012","unstructured":"Blumenfeld Z, Patel B, Leiba R, Zuckerman T . Gonadotropin-releasing hormone agonist may minimize premature ovarian failure in young women undergoing autologous stem cell transplantation. Fertil Steril 2012; 98: 1266\u20131270.","journal-title":"Fertil Steril"},{"key":"BFbmt2016150_CR21","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/sj.bmt.1705279","volume":"37","author":"K Nakagawa","year":"2006","unstructured":"Nakagawa K, Kanda Y, Yamashita H, Hosoi Y, Oshima K, Ohtomo K et al. Preservation of ovarian function by ovarian shielding when undergoing total body irradiation for hematopoietic stem cell transplantation: a report of two successful cases. Bone Marrow Transplant 2006; 37: 583\u2013587.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016150_CR22","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/bmt.2008.234","volume":"42","author":"K Nakagawa","year":"2008","unstructured":"Nakagawa K, Kanda Y, Yamashita H, Nakagawa S, Sasano N, Ohtomo K et al. Ovarian shielding allows ovarian recovery and normal birth in female hematopoietic SCT recipients undergoing TBI. Bone Marrow Transplant 2008; 42: 697\u2013699.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016150_CR23","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00277-013-1852-8","volume":"93","author":"Y Kanda","year":"2014","unstructured":"Kanda Y, Wada H, Yamasaki R, Kawamura K, Ishihara Y, Sakamoto K et al. Protection of ovarian function by two distinct methods of ovarian shielding for young female patients who receive total body irradiation. Ann Hematol 2014; 93: 287\u2013292.","journal-title":"Ann Hematol"},{"key":"BFbmt2016150_CR24","doi-asserted-by":"publisher","first-page":"e292","DOI":"10.1097\/MPH.0000000000000309","volume":"37","author":"N Ishibashi","year":"2015","unstructured":"Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Abe O, Saito T et al. Successful Pregnancy and Delivery After Radiation With Ovarian Shielding for Acute Lymphocytic Leukemia Before Menarche. J Pediatr Hematol Oncol 2015; 37: e292\u2013e294.","journal-title":"J Pediatr Hematol Oncol"},{"key":"BFbmt2016150_CR25","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1210\/jc.2006-0684","volume":"91","author":"AP Grigg","year":"2006","unstructured":"Grigg AP, Shuttleworth P, Reynolds J, Schwarer AP, Szer J, Bradstock K et al. Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endocrinol Metab 2006; 91: 3835\u20133843.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFbmt2016150_CR26","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1210\/jc.2004-2161","volume":"90","author":"K Kananen","year":"2005","unstructured":"Kananen K, Volin L, Laitinen K, Alfthan H, Ruutu T, V\u00e4lim\u00e4ki MJ . Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab 2005; 90: 3877\u20133885.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFbmt2016150_CR27","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1210\/jc.2006-2870","volume":"92","author":"L Tauchmanov\u00e0","year":"2007","unstructured":"Tauchmanov\u00e0 L, Colao A, Lombardi G, Rotoli B, Selleri C . Bone loss and its management in long-term survivors from allogeneic stem cell transplantation. J Clin Endocrinol Metab 2007; 92: 4536\u20134545.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFbmt2016150_CR28","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.clml.2013.05.014","volume":"13","author":"E Assouline","year":"2013","unstructured":"Assouline E, Crocchiolo R, Prebet T, Broussais F, Coso D, Gamerre M et al. Impact of reduced-intensity conditioning allogeneic stem cell transplantation on women's fertility. Clin Lymphoma Myeloma Leuk 2013; 13: 704\u2013710.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"BFbmt2016150_CR29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.2217\/fon.15.357","volume":"12","author":"I Meattini","year":"2016","unstructured":"Meattini I, Saieva C, Meacci F, Scotti V, De Luca Cardillo C, Desideri I et al. Impact of age on cytotoxic-induced ovarian failure in breast cancer treated with adjuvant chemotherapy and triptorelin. Future Oncol 2016; 12: 625\u2013635.","journal-title":"Future Oncol"},{"key":"BFbmt2016150_CR30","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1470-2045(05)70092-9","volume":"6","author":"WH Wallace","year":"2005","unstructured":"Wallace WH, Anderson RA, Irvine DS . Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 2005; 6: 209\u2013218.","journal-title":"Lancet Oncol"},{"key":"BFbmt2016150_CR31","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00001703-200310000-00003","volume":"15","author":"Z Blumenfeld","year":"2003","unstructured":"Blumenfeld Z . Gynaecologic concerns for young women exposed to gonadotoxic chemotherapy. Curr Opin Obstet Gynecol 2003; 15: 359\u2013370.","journal-title":"Curr Opin Obstet Gynecol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016150","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:23:18Z","timestamp":1648063398000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,6]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["BFbmt2016150"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.150","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,6]]},"assertion":[{"value":"30 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}